You are using an older browser version. Please use a supported version for the best MSN experience.

Jim Cramer on Biogen Earnings, Alzheimer's Drug

Jim Cramer breaks down his latest thoughts on Biogen's controversial Alzheimer's drug.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon